Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | ![]() SaneVax Offers Highly Sensitive HPV DNA Sequencing Test for HPV Vaccine SafetyAccording to documentation presented to the FDA prior to HPV vaccine approval, a woman exposed to vaccine-relevant HPV genotypes prior to vaccination may increase their risk of developing pre-cancerous lesions, or cervical cancer by up to 44.6%.
By: Norma Erickson Even though the CDC, FDA, and many practicing physicians say there is no need for HPV testing prior to vaccination, SaneVax believes it is essential to know whether or not you have been exposed to vaccine-relevant HPV genotypes before you vaccinate. The SaneVax team believes no one should take the risk of increasing their chance of developing cancerous, or pre-cancerous cells by using a vaccine meant to prevent that very thing. To insure this option is available to medical consumers, SaneVax has partnered with Dr. Sin Hang Lee, and Milford Medical Laboratory to offer low cost, highly sensitive HPV DNA PCR sequencing directly to medical consumers who are considering taking either one of the two HPV vaccines licensed for use in the United States, Gardasil or Cervarix. This test will detect any of the 100+ HPV genotypes and accurately identify which, if any, high-risk genotypes are present. Then consumers will have the knowledge they need to consult with their doctor and decide if HPV vaccination is a good option for them. The choice is yours: play russian roulette with HPV vaccines, or find out if you have been exposed to HPV before you vaccinate. Visit http://sanevax.org/ # # # SaneVax. Inc. believes only Safe, Affordable, Necessary & Effective vaccines and vaccination practices should be offered to the public. Their primary goal is to provide scientific information/ End
|
|